[SRNE] YoY Annual Result on 31-Dec-2013 [#FY]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
31-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#FY]
Profit Trend
YoY- -352.24%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Annual Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 8,152 4,590 3,825 460 584 529 683 51.11%
PBT -64,833 -13,760 -36,359 -21,911 -4,845 -3,236 -1,808 81.49%
Tax -896 36,314 -1,702 10 15 12 8 -
NP -60,923 -45,811 -34,657 -21,911 -4,845 -3,236 -1,808 79.62%
Tax Rate - - - - - - - -
Total Cost 69,075 50,401 38,482 22,371 5,429 3,766 2,491 73.88%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -747.34 -998.06 -906.07 -4,761.79 -830.00 -611.60 -264.94 18.84%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -1.21 -1.24 -1.30 -1.46 -0.42 -0.33 -0.20 34.95%
EPS Diluted -1.21 -1.24 -1.30 -1.46 -0.42 -0.33 -0.20 34.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.